Skip to content
CompletedPhase 4Results posted

The Impact of Perioperative Ketamine Infusion on Surgical Recovery

NCT04625283 · Vanderbilt University Medical Center

Closed to entry
Status
Not accepting participants
Phase 4
Phase
1,570
Target enrolment
1
Study sites
1 US states

What it is testing

Summary

In order to effectively treat surgical pain with the least amount of opioids required, a multi-modal approach must include medications with different mechanisms of actions at alternative receptors. In light of the opioid epidemic, medical providers at Vanderbilt University Medical Center (VUMC) are strategically combining these medications in a bundled pain-regimen after surgery. These regimens have been shown to decrease opioid consumption, improve surgical outcomes, and reduce hospital stays, thus coining the term 'enhanced recovery pathway'. The combination of these medications has an indisputable synergistic effect. However, it is unknown how each medication contributes individually to the overall efficacy of the pathway. This study will examine the effects of ketamine, within the constructs of a multimodal pain regimen, on a) length of stay, b) opioid consumption, and c) surgical outcomes after major abdominal surgery.

Summary as written by the trial’s own sponsor and published on ClinicalTrials.gov API v2. It is the sponsor’s description, reproduced unedited, not an assessment by this site.

What counts as success

Primary outcome measures

  • Length of Stay

    Measured over From surgery start until discharge, typically 3-5 days

A trial succeeds or fails on its primary outcome, declared in advance. Everything else it reports is secondary by definition.

Who can take part

Eligibility, as published

18 Years
Ages
All
Sex
Not accepted
Healthy volunteers
Inclusion Criteria: * 18 years old or greater * presenting at VUMC for abdominal surgery on the colorectal, ventral hernia or surgical oncology services on a weekday. Exclusion Criteria: * allergy or contraindication to ketamine * unable or refuse to receive a neuraxial or regional nerve block * patient refusal * direct transfer from operating room to intensive care unit with endotracheal tube placed * treating team elects to exclude the patient prior to study drug administration * abortion of planned surgical procedure

Where

1 study site

FacilityCityRegionCountry
Vanderbilt University Medical CenterNashvilleTennesseeUnited States

On the registry

Contact the trial directly

This site does not enrol anyone and is not involved in this trial. To ask about taking part, use the sponsor’s own contact details on the official registry record, which is also where the most current version of everything above lives.

Before you do, the preparation checklist lists what a site will ask you on a first call and what is worth asking them. It is free and collects nothing.

NCT04625283 on ClinicalTrials.gov →

Last updated in the registry 2025-02-04. Registry records change; this page reflects the data build of 2026-08-25.

Related

Where this trial sits